These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

623 related items for PubMed ID: 16635597

  • 1. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
    Lahlou-Laforet K, Alhenc-Gelas M, Pornin M, Bydlowski S, Seigneur E, Benetos A, Kierzin JM, Scarabin PY, Ducimetiere P, Aiach M, Guize L, Consoli SM.
    Am J Cardiol; 2006 May 01; 97(9):1287-91. PubMed ID: 16635597
    [Abstract] [Full Text] [Related]

  • 2. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO, Landin K, Johannsson G, Tengborn L, Bengtsson BA.
    Thromb Haemost; 1996 Sep 01; 76(3):422-8. PubMed ID: 8883281
    [Abstract] [Full Text] [Related]

  • 3. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C.
    Thromb Haemost; 1999 Feb 01; 81(2):275-80. PubMed ID: 10064006
    [Abstract] [Full Text] [Related]

  • 4. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
    Deepa R, Velmurugan K, Saravanan G, Dwarakanath V, Agarwal S, Mohan V.
    J Assoc Physicians India; 2002 Jul 01; 50():901-6. PubMed ID: 12126344
    [Abstract] [Full Text] [Related]

  • 5. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
    Sebestjen M, Zegura B, Guzic-Salobir B, Keber I.
    Wien Klin Wochenschr; 2001 Feb 15; 113(3-4):113-8. PubMed ID: 11253736
    [Abstract] [Full Text] [Related]

  • 6. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
    Scarabin PY, Aillaud MF, Amouyel P, Evans A, Luc G, Ferrières J, Arveiler D, Juhan-Vague I.
    Thromb Haemost; 1998 Nov 15; 80(5):749-56. PubMed ID: 9843166
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
    Ihnken K, Speiser W, Müller-Berghaus G, Beyersdorf F, Schlepper M, Satter P.
    Helv Chir Acta; 1992 Jan 15; 58(4):503-8. PubMed ID: 1582860
    [Abstract] [Full Text] [Related]

  • 10. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
    Farhan S, Winzer C, Tura A, Quehenberger P, Bieglmaier C, Wagner OF, Huber K, Waldhäusl W, Pacini G, Kautzky-Willer A.
    Eur J Clin Invest; 2006 May 15; 36(5):345-52. PubMed ID: 16634839
    [Abstract] [Full Text] [Related]

  • 11. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar 15; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 12. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy.
    Brazionis L, Rowley K, Jenkins A, Itsiopoulos C, O'Dea K.
    Arterioscler Thromb Vasc Biol; 2008 Apr 15; 28(4):786-91. PubMed ID: 18239151
    [Abstract] [Full Text] [Related]

  • 13. Absence of profound hyperinsulinism in polycystic ovary syndrome is associated with subtle elevations in the plasminogen activator inhibitor system.
    Sills ES, Drews CD, Perloe M, Tucker MJ, Kaplan CR, Palermo GD.
    Gynecol Endocrinol; 2003 Jun 15; 17(3):231-7. PubMed ID: 12857431
    [Abstract] [Full Text] [Related]

  • 14. Independent relation of vital exhaustion and inflammation to fibrinolysis in apparently healthy subjects.
    von Känel R, Frey K, Fischer J.
    Scand Cardiovasc J; 2004 Mar 15; 38(1):28-32. PubMed ID: 15204244
    [Abstract] [Full Text] [Related]

  • 15. Effects of gemfibrozil and ciprofibrate on plasma levels of tissue-type plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen in hyperlipidaemic patients.
    Kockx M, de Maat MP, Knipscheer HC, Kastelein JJ, Kluft C, Princen HM, Kooistra T.
    Thromb Haemost; 1997 Oct 15; 78(4):1167-72. PubMed ID: 9364979
    [Abstract] [Full Text] [Related]

  • 16. Plasminogen activator inhibitor 1 is elevated in the children of men with premature myocardial infarction.
    Rallidis LS, Megalou AA, Papageorgakis NH, Trikas AG, Chatzidimitriou GI, Tsitouris GK.
    Thromb Haemost; 1996 Sep 15; 76(3):417-21. PubMed ID: 8883280
    [Abstract] [Full Text] [Related]

  • 17. Fibrinolytic proteins and progression of coronary artery disease in relation to gemfibrozil therapy.
    Hamsten A, Syvänne M, Silveira A, Luong LA, Nieminen MS, Humphries S, Frick MH, Taskinen MR.
    Thromb Haemost; 2000 Mar 15; 83(3):397-403. PubMed ID: 10744143
    [Abstract] [Full Text] [Related]

  • 18. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D, Kremplewska-Nalezyta E, Gadomska G, Zastawna E, Michalski A, Drewniak W.
    Med Sci Monit; 2000 Mar 15; 6(4):684-91. PubMed ID: 11208392
    [Abstract] [Full Text] [Related]

  • 19. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW, Helmy A, Ludlam C, Webb DJ, Hayes PC, Newby DC.
    Thromb Res; 2008 Mar 15; 121(5):675-80. PubMed ID: 17870147
    [Abstract] [Full Text] [Related]

  • 20. High intakes of trans monounsaturated fatty acids taken for 2 weeks do not influence procoagulant and fibrinolytic risk markers for CHD in young healthy men.
    Sanders TA, Oakley FR, Crook D, Cooper JA, Miller GJ.
    Br J Nutr; 2003 Jun 15; 89(6):767-76. PubMed ID: 12828793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.